Advertisement
Australia markets closed

  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     

  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     

  • AUD/USD

    0.6426
    0.0000 (-0.00%)
     

  • OIL

    82.17
    -0.56 (-0.68%)
     

  • GOLD

    2,395.50
    -2.50 (-0.10%)
     

  • Bitcoin AUD

    101,778.21
    +4,915.48 (+5.07%)
     

  • CMC Crypto 200

    1,342.16
    +29.53 (+2.30%)
     

  • AUD/EUR

    0.6020
    -0.0011 (-0.19%)
     

  • AUD/NZD

    1.0892
    +0.0017 (+0.16%)
     

  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     

  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     

  • FTSE

    7,843.29
    -33.76 (-0.43%)
     

  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     

  • DAX

    17,750.29
    -87.11 (-0.49%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Can Walgreens Succeed in This Market Where CVS Failed?

Alex Carchidi, The Motley Fool
·4-min read
Can Walgreens Succeed in This Market Where CVS Failed?

When CVS Health (NYSE: CVS) said on May 14 that it would exit its clinical trial services business after just two years in operation, management at Walgreens Boots Alliance (NASDAQ: WBA) was quick to confirm that it would still be moving forward full speed with building out its own service. Now, the smaller pharmacy chain will have the benefit of one less major competitor trying to work with drug developers to build out their clinical trials. Why bother to get into clinical trials in the first place?

Continue reading